Viracta Therapeutics (VIRX) Stock Chart & Stock Price History $0.02 +0.00 (+8.82%) As of 05/21/2025 03:28 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Viracta Therapeutics Stock Price Performance The Viracta Therapeutics (VIRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 97.57%, with a year-to-date return of -88.50%. In the past month, the stock has increased 15.63%, reflecting recent market activity. As of the latest close, Viracta Therapeutics traded at $0.02 with a market cap of $735,000.00 and volume of 10,543 shares. Receive VIRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+8.82%1 Month Performance+15.63%3 Month Performance-50.00%Year-To-Date Performance-88.50%1 Year Performance-97.57% VIRX Stock Chart for Thursday, May, 22, 2025 VIRX Chart by TradingView Viracta Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$0.02$0.02+8.82%$0.02$0.0210,543 shs$735,000.0005/20/2025$0.02$0.02$0.02$0.0212,606 shs$676,000.0005/19/2025$0.02$0.02$0.02$0.0284,738 shs$676,000.0005/16/2025$0.02$0.02-2.86%$0.02$0.022,634 shs$676,000.0005/15/2025$0.02$0.02+2.94%$0.02$0.0242,221 shs$696,000.0005/14/2025$0.02$0.02-3.41%$0.02$0.02196,649 shs$676,000.0005/13/2025$0.02$0.02-7.37%$0.02$0.02146,423 shs$699,000.0005/12/2025$0.02$0.02+11.76%$0.02$0.0230,522 shs$755,000.0005/09/2025$0.02$0.02$0.02$0.0237,031 shs$676,000.0005/08/2025$0.02$0.02-2.30%$0.02$0.0217,498 shs$676,000.00 Get the Latest News and Ratings for VIRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$0.02$0.02-13.00%$0.02$0.0248,091 shs$692,000.0005/06/2025$0.02$0.02+18.34%$0.02$0.02221,204 shs$795,000.0005/05/2025$0.02$0.02+2.42%$0.02$0.023,235 shs$672,000.0005/02/2025$0.02$0.02-14.51%$0.02$0.02179,346 shs$656,000.0005/01/2025$0.02$0.02-7.66%$0.02$0.0214,689 shs$767,000.0004/30/2025$0.02$0.02+26.67%$0.02$0.0236,507 shs$831,000.0004/29/2025$0.02$0.02-14.51%$0.02$0.0226,952 shs$656,000.0004/28/2025$0.02$0.02-12.27%$0.02$0.0227,513 shs$767,000.0004/25/2025$0.02$0.02+33.33%$0.02$0.02301,356 shs$874,000.0004/24/2025$0.02$0.02+0.61%$0.02$0.024,321 shs$656,000.0004/23/2025$0.02$0.02+2.50%$0.02$0.0272,021 shs$652,000.0004/22/2025$0.02$0.02+3.23%$0.02$0.0264,164 shs$636,000.0004/21/2025$0.02$0.02-1.90%$0.02$0.0252,645 shs$616,000.00 Related Companies PPBT Stock Price Chart GRI Stock Price Chart ARAV Stock Price Chart REVB Stock Price Chart PWUP Stock Price Chart INM Stock Price Chart QLGN Stock Price Chart KTTA Stock Price Chart VCNX Stock Price Chart PTN Stock Price Chart Receive VIRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VIRX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viracta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viracta Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VIRX Stock Free VIRX Stock Alerts